Serial 74165511
Live / Registered — Registered and renewed (as of 25 Mar 2022)
What this means for you
Registered since 17 Nov 1992. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 17 Nov 2022).
Record
- Serial number
- 74165511
- Registration number
- 1732405
- Mark type
- Design / logo
- Filed
- 06 May 1991
- Published for opposition
- 25 Aug 1992
- Registered
- 17 Nov 1992
- Next maintenance due
- 17 Nov 2022
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for use in the treatment of allergic conditions, cardiovascular diseases, diabetic states, [ diarrhea management, ] infectious diseases, inflammatory conditions, metabolic disorders, muscle spasms, pain conditions, psychiatric disorders, and pulmonary obstructions
Owner
- MYLAN, INC., Canonsburg, PA, US
- MYLAN LABORATORIES, INC., CANONSBURG, PA, US
- Mylan Pharmaceuticals Inc., Morgantown, WV, US
- Mylan Pharmaceuticals Inc., Morgantown, WV, US
- Mylan Pharmaceuticals Inc., Morgantown, WV, US
Prosecution history
- 25 Mar 2022 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 25 Mar 2022 — REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)
- 25 Mar 2022 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 25 Mar 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 18 Nov 2021 — TEAS SECTION 8 & 9 RECEIVED
- 17 Nov 2021 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 12 May 2014 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 12 May 2014 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 12 May 2014 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 12 May 2014 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 19 Feb 2014 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 19 Dec 2012 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 16 Feb 2012 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 16 Feb 2012 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 16 Feb 2012 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED